Sensydia - About the company
Sensydia is a series A company based in Los Angeles (United States), founded in 2015. It operates as a Cardio-respiratory monitoring device. Sensydia has raised $17.8M in funding from Orlando Health. The company has 535 active competitors, including 118 funded and 35 that have exited. Its top competitors include companies like AliveCor, iRhythm Tech and Eko.
Company Details
Cardio-respiratory monitoring device. It develops a wireless, non-invasive Cardio-Respiratory monitoring device that will help patients measure real-time heart function. The company is operating in stealth mode.
- Website
- www.sensydia.com/
- Email ID
- *****@sensydia.com
Key Metrics
Founded Year
2015
Location
Los Angeles, United States
Stage
Series A
Total Funding
$17.8M in 7 rounds
Latest Funding Round
Investors
Ranked
52nd among 535 active competitors
Employee Count
14 as on May 31, 2026
Legal entities associated with Sensydia
Sensydia is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SENSYDIA CORPORATION CIN: - , Belgium, Active | - | - | - |
Sign up to download Sensydia's company profile
Sensydia's funding and investors
Sensydia has raised a total funding of $17.8M over 7 rounds. Its first funding round was on Aug 01, 2016. Its latest funding round was a Grant (prize money) round on Apr 16, 2025 for $*****. 1 investor participated in its latest round. Sensydia has 8 institutional investors.
Here is the list of recent funding rounds of Sensydia:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 16, 2025 | 3101257 | Grant (prize money) | 7946854 | 6395211 | 7857248 | 3243958 |
Jun 05, 2023 | 9315427 | Grant (prize money) | 2226551 | 6293905 | 2903156 | |
May 09, 2023 | 9191581 | Series A | 3934091 | 3687072 |
View details of Sensydia's funding rounds and investors
Sensydia's founders and board of directors
Founder? Claim ProfileSensydia's employee count trend
Sensydia has 14 employees as of May 26. Here is Sensydia's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sensydia's Competitors and alternates
Top competitors of Sensydia include AliveCor, iRhythm Tech and Eko. Here is the list of Top 10 competitors of Sensydia, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AliveCor 2010, Mountain View (United States), Series F | Developer of remote cardiac monitoring solutions and related analysis software | $114M | 74/100 | |
2nd | iRhythm Tech 2006, San Francisco (United States), Public | Provider of cloud-based cardiac rhythm monitoring devices | $98.9M | 73/100 | |
3rd | Eko 2012, Oakland (United States), Series D | Provider of AI-based remote patient monitoring platform for cardiac health | $195M | 72/100 | |
4th | Developer of a digital health platform rewarding users for health monitoring | $12M | 66/100 | ||
5th | Welltory 2016, Redwood City (United States), Seed | Online health and wellness tracking and training platform | $1M | 63/100 | |
6th | Element Science 2013, San Francisco (United States), Series C | Wearable therapeutic device for treating sudden cardiac arrest | $193M | 61/100 | |
7th | HeartSciences 2007, Austin (United States), Public | Provider of a screening device for the early detection of cardiac dysfunction | $31.7M | - | 60/100 |
8th | Provider of AI and sensors-based post care solutions | $15M | 60/100 | ||
9th | Lifesignals 2008, Milpitas (United States), Series C | Provider of AI‑driven wireless wearable biosensors for remote monitoring of patients | $15.7M | 60/100 | |
10th | ZOLL AEDs 1983, Chelmsford (United States), Acquired | Developer of medical devices and software solutions for emergency care | - | 60/100 | |
52nd | Sensydia 2015, Los Angeles (United States), Series A | Cardio-respiratory monitoring device | $17.8M | 42/100 |
Looking for more details on Sensydia's competitors? Click here to see the top ones
Sensydia's Investments and acquisitions
Sensydia has made no investments or acquisitions yet.
Reports related to Sensydia
Here is the latest report on Sensydia's geography:
News related to Sensydia
•
Sensydia names Rusty Page President & COO to boost its Cardiac Performance System.
Business Wire•May 06, 2025•Sensydia
•
Sensydia CPS™ accurately measures pulmonary artery pressure non-invasively, new data shows.Business Wire•Mar 31, 2025•Sensydia
•
•
Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platformBusiness Wire•May 09, 2023•Sensydia, Orlando Health, Colle Capital, Frontier Venture Capital and 2 others
•
Sensydia Raises $8M Funding Round for Breakthrough Cardiac Assessment PlatformMedical Product Outsourcing•May 09, 2023•Sensydia, Orlando Health, Colle Capital, Frontier Venture Capital
•
•
•
Sensydia completes enrollment in study for AI-powered cardiac monitoring deviceMassDevice•Feb 06, 2023•Sensydia
•
Sensydia Receives FDA Breakthrough Device Designation for CPSTM Non-Invasive Cardiac Monitoring DeviceMedical Device News•Jan 19, 2022•Sensydia
•
Sensydia Appoints President and CEOMedical Product Outsourcing•Nov 12, 2019•Sensydia, Smith+Nephew, Medtronic, Boston Scientific and 1 other
Are you a Founder ?
FAQs about Sensydia
Explore our recently published companies
- Cinux - 2012 founded, Unfunded company
- St Cloud Technical - St. Cloud based, 1948 founded, Funding Raised company
- Fira - Indonesia based, 2015 founded, Unfunded company
- Antigravity Investments - Berkeley based, 2016 founded, Funding Raised company
- Clear Dynamics - Series B company
- Feinheit - Zurich based, 2006 founded, Unfunded company
